{"title":"探索膜活性头孢菌素衍生物作为抗金黄色葡萄球菌生物膜和顽固菌的强效抗菌剂","authors":"Shengcong Chen, Ye Qu, Ruirui Li, Maxwell Ampomah-Wireko, Hongtao Kong, Daran Li, Meng Wang, Chen Gao, Shangshang Qin, Jifeng Liu, Zhenya Wang, Muchen Zhang, En Zhang","doi":"10.1016/j.ejmech.2025.117484","DOIUrl":null,"url":null,"abstract":"Developing innovative antimicrobial agents is essential in the fight against drug-resistant bacteria, as well as biofilms and persistent bacteria. In this study, four series of amphiphilic cephalosporin derivatives were synthesized. Most of the compounds showed good activity against Gram-positive bacteria, among which membrane-active cephalosporin <strong>15e</strong> showed high activity against <em>Staphylococcus aureus</em>. Furthermore, <strong>15e</strong> can maintain antimicrobial activity in mammalian body fluids and does not develop detectable resistance. Antibacterial mechanism studies demonstrated that the compound <strong>15e</strong> can destroy the bacterial cell membrane, causing leakage of intracellular nucleic acids and proteins. Moreover, it can also suppress bacterial metabolic activity and induce the accumulation of reactive oxygen species (ROS) in the bacteria. Of greater significance, compound <strong>15e</strong> effectively prevented the formation of biofilms and eradicated established biofilms and persister cells. Notably, compound <strong>15e</strong> exhibited potent <em>in vivo</em> antibacterial efficacy, which was better than cephalothin. These findings suggest that <strong>15e</strong> has a potential to become a drug candidate for treating bacterial infections.","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"31 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Exploration of membrane-active cephalosporin derivatives as potent antibacterial agents against Staphylococcus aureus biofilms and persisters\",\"authors\":\"Shengcong Chen, Ye Qu, Ruirui Li, Maxwell Ampomah-Wireko, Hongtao Kong, Daran Li, Meng Wang, Chen Gao, Shangshang Qin, Jifeng Liu, Zhenya Wang, Muchen Zhang, En Zhang\",\"doi\":\"10.1016/j.ejmech.2025.117484\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Developing innovative antimicrobial agents is essential in the fight against drug-resistant bacteria, as well as biofilms and persistent bacteria. In this study, four series of amphiphilic cephalosporin derivatives were synthesized. Most of the compounds showed good activity against Gram-positive bacteria, among which membrane-active cephalosporin <strong>15e</strong> showed high activity against <em>Staphylococcus aureus</em>. Furthermore, <strong>15e</strong> can maintain antimicrobial activity in mammalian body fluids and does not develop detectable resistance. Antibacterial mechanism studies demonstrated that the compound <strong>15e</strong> can destroy the bacterial cell membrane, causing leakage of intracellular nucleic acids and proteins. Moreover, it can also suppress bacterial metabolic activity and induce the accumulation of reactive oxygen species (ROS) in the bacteria. Of greater significance, compound <strong>15e</strong> effectively prevented the formation of biofilms and eradicated established biofilms and persister cells. Notably, compound <strong>15e</strong> exhibited potent <em>in vivo</em> antibacterial efficacy, which was better than cephalothin. These findings suggest that <strong>15e</strong> has a potential to become a drug candidate for treating bacterial infections.\",\"PeriodicalId\":314,\"journal\":{\"name\":\"European Journal of Medicinal Chemistry\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2025-03-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejmech.2025.117484\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejmech.2025.117484","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Exploration of membrane-active cephalosporin derivatives as potent antibacterial agents against Staphylococcus aureus biofilms and persisters
Developing innovative antimicrobial agents is essential in the fight against drug-resistant bacteria, as well as biofilms and persistent bacteria. In this study, four series of amphiphilic cephalosporin derivatives were synthesized. Most of the compounds showed good activity against Gram-positive bacteria, among which membrane-active cephalosporin 15e showed high activity against Staphylococcus aureus. Furthermore, 15e can maintain antimicrobial activity in mammalian body fluids and does not develop detectable resistance. Antibacterial mechanism studies demonstrated that the compound 15e can destroy the bacterial cell membrane, causing leakage of intracellular nucleic acids and proteins. Moreover, it can also suppress bacterial metabolic activity and induce the accumulation of reactive oxygen species (ROS) in the bacteria. Of greater significance, compound 15e effectively prevented the formation of biofilms and eradicated established biofilms and persister cells. Notably, compound 15e exhibited potent in vivo antibacterial efficacy, which was better than cephalothin. These findings suggest that 15e has a potential to become a drug candidate for treating bacterial infections.
期刊介绍:
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.